search
Back to results

Cycling Deep Brain Stimulation on Parkinson's Disease Gait (DBS)

Primary Purpose

Parkinson Disease

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Cycling deep brain stimulation
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of idiopathic Parkinson's disease
  • Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment
  • Hoehn & Yahr stage between 2-4 during off-medication
  • Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale
  • Willingness to comply with all study procedures

Exclusion Criteria:

  • Active moderate/severe psychiatric condition
  • Active infection or other uncontrolled moderate/grave comorbidities
  • Treatment with experimental drug
  • Pregnancy or breast-feeding

Sites / Locations

  • Hospital das Clínicas da Faculdade de Medicina da USPRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Regular Continuous High Frequency

Cycling High Frequency

Continuous Low Frequency

Cycling Low Frequency

Arm Description

Patient remains 2 weeks in the currently chosen stimulation protocol.

Patient is stimulated with the same polarity, voltage/current, pulse width and frequency as the currently chosen stimulation protocol, but with cycling stimulation: 40sec On - 02 sec OFF

Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz). Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.

Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz) and cycling stimulation: 40sec On - 02 sec OFF. Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.

Outcomes

Primary Outcome Measures

Change in the part II of the Unified Parkinson's disease rating scale
The part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.
Change in the New Freezing of Gait Questionnaire
The New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.

Secondary Outcome Measures

Change in Falls Efficacy Scale
The Falls Efficacy Scale (FES) is a sixteen-item test rated on a 10-point scale from not confident at all to completely confident. It is correlated with difficulty getting up from a fall and level of anxiety. Scores vary from 16 - 64. Higher scores mean a worse outcome.
Change in The Parkinson's Disease Questionnaire (PDQ-39)
This questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. The 39 item questionnaire offers a patient reported measure of health status and quality of life and is the most frequently used disease-specific health status measure.Scores vary from 0 - 156. Higher scores mean a worse outcome.
Change in Activities-Specific Balance Confidence Scale (ABC scale)
The ABC scale is a self-report measure of balance in performing various activities without losing balance or experiencing a sense of unsteadiness. Scores vary from 0 - 100. Higher scores mean a better outcome.
Number of falls
Patients will be questioned about number of times they experienced falls in the last 2 weeks. Higher numbers mean a worse outcome.

Full Information

First Posted
May 25, 2020
Last Updated
June 19, 2020
Sponsor
University of Sao Paulo General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04408573
Brief Title
Cycling Deep Brain Stimulation on Parkinson's Disease Gait
Acronym
DBS
Official Title
Effects of Cycling Deep Brain Stimulation on Parkinson's Disease Gait
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 19, 2020 (Actual)
Primary Completion Date
May 29, 2021 (Anticipated)
Study Completion Date
December 29, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Our hypothesis is that cycling DBS stimulation would be superior or non-inferior to regular DBS stimulation in Parkinson's disease patients with gait impairment. The objective of this study is compare gait disorders in patients with Parkinson's disease and DBS in 4 different scenarios: 1) regular continuous high frequency (>130Hz) stimulation, 2) cycling high frequency (>130Hz) stimulation (40sec on, 2sec off), 3) low-frequency (80Hz) continuous stimulation and 4) cycling low frequency (80Hz) stimulation (40sec on, 2sec off)
Detailed Description
Gait disorders such as falls, freezing of gait, reduction of speed, shuffling, and multi-stepped turning are common in patients with moderate and advanced Parkinson's disease. Compared to appendicular symptoms (bradykinesia, tremor, and rigidity), gait disorders tend to be more resistant to medical and regular deep brain stimulation treatment, and greatly impairs patients' quality of life and daily living activities. Some stimulation strategies have been tried to improve gait in Parkinson's disease patients, but so far most of them resulted in concomitant worsening of appendicular symptoms. However, new stimulation strategies such as cycling stimulation can potentially improve gait disorders without impairment of appendicular symptoms.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
2 weeks of regular continuous high frequency (>130Hz) stimulation, 2 weeks of cycling high frequency (>130Hz) stimulation (40sec on, 2sec off), 2 weeks of low-frequency (80Hz) continuous stimulation and 2 weeks of cycling low frequency (80Hz) stimulation (40sec on, 2sec off)
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Regular Continuous High Frequency
Arm Type
No Intervention
Arm Description
Patient remains 2 weeks in the currently chosen stimulation protocol.
Arm Title
Cycling High Frequency
Arm Type
Experimental
Arm Description
Patient is stimulated with the same polarity, voltage/current, pulse width and frequency as the currently chosen stimulation protocol, but with cycling stimulation: 40sec On - 02 sec OFF
Arm Title
Continuous Low Frequency
Arm Type
Experimental
Arm Description
Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz). Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.
Arm Title
Cycling Low Frequency
Arm Type
Experimental
Arm Description
Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz) and cycling stimulation: 40sec On - 02 sec OFF. Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.
Intervention Type
Other
Intervention Name(s)
Cycling deep brain stimulation
Intervention Description
Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF
Primary Outcome Measure Information:
Title
Change in the part II of the Unified Parkinson's disease rating scale
Description
The part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Title
Change in the New Freezing of Gait Questionnaire
Description
The New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Secondary Outcome Measure Information:
Title
Change in Falls Efficacy Scale
Description
The Falls Efficacy Scale (FES) is a sixteen-item test rated on a 10-point scale from not confident at all to completely confident. It is correlated with difficulty getting up from a fall and level of anxiety. Scores vary from 16 - 64. Higher scores mean a worse outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Title
Change in The Parkinson's Disease Questionnaire (PDQ-39)
Description
This questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. The 39 item questionnaire offers a patient reported measure of health status and quality of life and is the most frequently used disease-specific health status measure.Scores vary from 0 - 156. Higher scores mean a worse outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Title
Change in Activities-Specific Balance Confidence Scale (ABC scale)
Description
The ABC scale is a self-report measure of balance in performing various activities without losing balance or experiencing a sense of unsteadiness. Scores vary from 0 - 100. Higher scores mean a better outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Title
Number of falls
Description
Patients will be questioned about number of times they experienced falls in the last 2 weeks. Higher numbers mean a worse outcome.
Time Frame
Baseline + after 2 weeks + after 4 weeks + after 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of idiopathic Parkinson's disease Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment Hoehn & Yahr stage between 2-4 during off-medication Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale Willingness to comply with all study procedures Exclusion Criteria: Active moderate/severe psychiatric condition Active infection or other uncontrolled moderate/grave comorbidities Treatment with experimental drug Pregnancy or breast-feeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rubens G Cury, MD, PhD
Phone
55 11 26617877
Email
rubens_cury@usp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Carina C França, MD
Phone
55 11 26617877
Email
carina.fr@usp.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rubens G Cury, MD, PhD
Organizational Affiliation
University of Sao Paulo General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital das Clínicas da Faculdade de Medicina da USP
City
São Paulo
State/Province
SP
ZIP/Postal Code
05403000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rubens G Cury, MD PhD
Phone
55 11 26617877
Email
rubens_cury@usp.br
First Name & Middle Initial & Last Name & Degree
Carina C França, MD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
all IPD that underlie results in a publication
IPD Sharing Time Frame
Data will be made available indefinitely upon reasonable request from other authors
IPD Sharing Access Criteria
Investigator Rubens Cury will analyse request and decide upon reasonability

Learn more about this trial

Cycling Deep Brain Stimulation on Parkinson's Disease Gait

We'll reach out to this number within 24 hrs